{"id":42921,"date":"2023-06-08T16:07:29","date_gmt":"2023-06-08T08:07:29","guid":{"rendered":"https:\/\/biopioneer.com.tw\/?p=42921"},"modified":"2023-06-09T17:12:33","modified_gmt":"2023-06-09T09:12:33","slug":"bevacizumab-elisa-kit-%e8%b2%a8%e8%99%9fabx395076","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=42921","title":{"rendered":"Bevacizumab ELISA Kit | \u8ca8\u865fabx395076"},"content":{"rendered":"

\u751f\u7269\u4eff\u88fd\u85e5ELISA\u6aa2\u6e2c | Research into Biosimilar antibodies<\/span><\/span><\/strong><\/span><\/p>\n

<\/p>\n

Biosimilar ELISA Kits<\/span><\/p>\n

\u8853\u8a9e\u751f\u7269\u4eff\u88fd\u85e5\u662f\u6307\u7d50\u69cb(structure)\u3001\u529f\u80fd(function)\u548c\u529f\u6548(efficacy)\u8207 FDA \u6279\u51c6\u7684\u751f\u7269\u88fd\u85e5\u76f8\u4f3c\u7684\u751f\u7269\u88fd\u54c1(biological products)\u3002\u751f\u7269\u4eff\u88fd\u85e5(Biosimilars)\u65e8\u5728\u6a21\u4eff\u85e5\u7269(mimic drugs )\uff0c\u96d6\u7136\u5b83\u5011\u4e26\u4e0d\u76f8\u540c\uff0c\u4f46\u5b83\u5011\u5177\u6709\u76f8\u4f3c\u7684\u6d3b\u6027( similar activity)\u3002\u8fc4\u4eca\u70ba\u6b62\uff0c\u7372\u51c6\u7528\u65bc\u81e8\u5e8a\u7684\u751f\u7269\u4eff\u88fd\u85e5(biosimilar proteins)\u548c\u6297\u9ad4\u4e26\u4e0d\u591a\uff0c\u4f46\u8a31\u591a\u5df2\u6210\u70ba\u6709\u7528\u7684\u7814\u7a76\u5de5\u5177\uff0c\u56e0\u70ba\u5b83\u5011\u80fd\u5920\u4ee5\u4e00\u7a2e\u7c21\u55ae\u4e14\u6210\u672c\u8f03\u4f4e\u7684\u65b9\u5f0f\u8a55\u4f30\u8a31\u591a\u751f\u7269\u88fd\u85e5(biopharmaceuticals )\u7684\u6548\u679c\u3002Abbexa \u70ba\u591a\u7a2e\u751f\u7269\u4eff\u88fd\u85e5\u6297\u9ad4\u63d0\u4f9b\u7bc4\u570d\u5ee3\u6cdb\u7684 ELISA \u8a66\u5291\u76d2\u3002<\/p>\n

Infliximab ELISA Kit\u00a0\u8ca8\u865fabx395019<\/span><\/strong><\/span><\/h2>\n

Infliximab ELISA Kit is a quantitative ELISA kit for detection of Infliximab.<\/p>\n

\u5075\u6e2c\u9748\u654f\u5ea60.31 \u03bcg\/ml – 5 \u03bcg\/ml<\/p>\n

\u82f1\u592b\u5229\u6614\u55ae\u6297ELISA\u8a66\u5291\u76d2(Infliximab ELISA Kit) \u662f\u7528\u65bc\u6aa2\u6e2c\u82f1\u592b\u5229\u6614\u55ae\u6297(Infliximab)\u7684\u5b9a\u91cfELISA\u8a66\u5291\u76d2\u3002\u82f1\u592b\u5229\u6614\u55ae\u6297(Infliximab)\u662f\u7b2c\u4e00\u500b\u88ab\u6279\u51c6\u7528\u65bc\u81e8\u5e8a\u7684\u751f\u7269\u985e\u4f3c\u85e5\u3002\u5b83\u662f\u4e00\u7a2e\u7528\u65bc\u6cbb\u7642\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7684\u5d4c\u5408\u55ae\u514b\u9686\u6297\u9ad4(chimeric monoclonal antibody)\u3002\u82f1\u592b\u5229\u6614\u55ae\u6297(Infliximab)\u901a\u904e\u8207\u4eba\u816b\u7624\u58de\u6b7b\u56e0\u5b50 (active human tumour necrosis factor, hTNFa) \u7d50\u5408\u4f75\u963b\u6b62\u5176\u5411\u5404\u7a2e\u7d30\u80de\u985e\u578b\u8868\u9762\u7684 TNFa \u53d7\u9ad4\u767c\u51fa\u4fe1\u865f\u4f86\u6e1b\u5c11\u9ad4\u5167hTNFa\u6d3b\u6027\u4eba\u816b\u7624\u58de\u6b7b\u56e0\u5b50 (active human tumour necrosis factor, hTNFa) \u7684\u6578\u91cf\u3002 hTNFa\u6d3b\u6027\u4eba\u816b\u7624\u58de\u6b7b\u56e0\u5b50 (active human tumour necrosis factor, hTNFa) \u662f\u89f8\u767c\u548c\u7dad\u6301\u708e\u75c7\u53cd\u61c9\u7684\u95dc\u9375\u7d30\u80de\u56e0\u5b50\u4e4b\u4e00\u3002\u82f1\u592b\u5229\u6614\u55ae\u6297(Infliximab)\u7528\u65bc\u6cbb\u7642\u9280\u5c51\u75c5(psoriasis)\u3001\u514b\u7f85\u6069\u75c5( Crohn’s disease)\u3001\u5f37\u76f4\u6027\u810a\u67f1\u708e(ankylosing spondylitis)\u3001\u9280\u5c51\u75c5\u95dc\u7bc0\u708e( psoriatic arthritis)\u3001\u985e\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e(rheumatoid arthritis)\u3001\u6f70\u760d\u6027\u7d50\u8178\u708e(ulcerative colitis)\u3002<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Target<\/td>\nInfliximab<\/td>\n<\/tr>\n
Reactivity<\/td>\nHuman<\/td>\n<\/tr>\n
Tested Applications<\/td>\nELISA<\/td>\n<\/tr>\n
Recommended dilutions<\/td>\nOptimal dilutions\/concentrations should be determined by the end user.<\/td>\n<\/tr>\n
Storage<\/td>\nShipped at 4 \u00b0C. Upon receipt, store the kit according to the storage instruction in the kit’s manual.<\/td>\n<\/tr>\n
Validity<\/td>\nThe validity for this kit is 6 months.<\/td>\n<\/tr>\n
Stability<\/td>\nThe stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.<\/td>\n<\/tr>\n
Test Range<\/td>\n0.31 \u03bcg\/ml – 5 \u03bcg\/ml<\/td>\n<\/tr>\n
Sensitivity<\/td>\n0.16 \u03bcg\/ml<\/td>\n<\/tr>\n
Detection Method<\/td>\nColorimetric<\/td>\n<\/tr>\n
Assay Data<\/td>\nQuantitative<\/td>\n<\/tr>\n
Sample Type<\/td>\nSerum and plasma.<\/td>\n<\/tr>\n
Availability<\/td>\nShipped within 5-12 working days.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Bevacizumab ELISA Kit | \u8ca8\u865fabx395076<\/span><\/strong><\/span><\/h2>\n

Bevacizumab ELISA Kit is a quantitative ELISA kit for detection of Bevacizumab.<\/p>\n

\u5075\u6e2c\u9748\u654f\u5ea60.31 \u03bcg\/ml – 5 \u03bcg\/ml<\/p>\n

bevacizumab\u662f\u4e00\u7a2e\u91cd\u7d44\u7684\u4eba\u5316\u55ae\u682a\u6297\u9ad4\uff0c\u53ef\u9078\u64c7\u6027\u5730\u7d50\u5408\u81f3\u4eba\u985e\u8840\u7ba1\u5167\u76ae\u751f\u9577\u56e0\u5b50(VEGF)\u4e26\u4e2d\u548c\u5176\u751f\u7269\u6d3b\u6027\u3002Bevacizumab\u542b\u6709\u4eba\u985e\u7684\u67b6\u69cb\u5340(framework regions)\u53ca\u53ef\u8207VEGF\u7d50\u5408\u4eba\u5316\u9f20\u6297\u9ad4\u4e0a\u7684\u6297\u539f\u7d50\u5408\u5340(antigen binding regions)\u3002bevacizumab\u6216\u5176\u6bcd\u9f20\u6297\u9ad4\u6cbb\u7642\u4e4b\u7d50\u679c\u53ef\u5f97\u77e5\u5176\u5c0d\u4eba\u985e\u7684\u764c\u75c7\u5305\u62ec\u5927\u8178\u764c\u3001\u4e73\u764c\u3001\u80f0\u81df\u764c\u53ca\u524d\u5217\u817a\u764c\u7b49\u764c\u75c7\u4e2d\u4e4b\u5ee3\u6cdb\u7684\u6297\u816b\u7624\u6d3b\u6027\uff0c\u8f49\u79fb\u6027\u75be\u75c5\u7684\u9032\u884c\u88ab\u6291\u5236\u4e14\u5fae\u8840\u7ba1\u7684\u901a\u900f\u6027\u4ea6\u964d\u4f4e\u3002Bevacizumab ELISA Kit\u662f\u7528\u65bc\u6aa2\u6e2c\u8c9d\u4f10\u73e0\u55ae\u6297(Bevacizumab)\u7684\u5b9a\u91cfELISA\u8a66\u5291\u76d2\u3002\u8c9d\u4f10\u73e0\u55ae\u6297(Bevacizumab)\u662f\u4e00\u7a2e\u91cd\u7d44\u4eba IgG1 \u55ae\u514b\u9686\u6297\u9ad4(recombinant human IgG1 monoclonal antibody)\uff0c\u5c0d\u6240\u6709\u4eba\u8840\u7ba1\u5167\u76ae\u751f\u9577\u56e0\u5b50-A (vascular endothelial growth factor-A , VEGF-A) \u4e9e\u578b\u5177\u6709\u7279\u7570\u6027\u3002\u4eba\u6e90\u5316\u6297 VEGF \u55ae\u514b\u9686\u6297\u9ad4(anti-VEGF monoclonal antibody), \u8c9d\u4f10\u73e0\u55ae\u6297(Bevacizumab)\u5df2\u88ab FDA \u6279\u51c6\u4f5c\u70ba\u806f\u5408\u5316\u7642\u6cbb\u7642\u8f49\u79fb\u6027\u7d50\u76f4\u8178\u764c\u7684\u4e00\u7dda\u6cbb\u7642\u85e5\u7269\u3002\u8c9d\u4f10\u73e0\u55ae\u6297(Bevacizumab)\u7684\u85e5\u4ee3\u52d5\u529b\u5b78\u7279\u6027\u8207\u5178\u578b\u7684\u4eba\u6e90\u5316\u55ae\u514b\u9686\u6297\u9ad4\u4e00\u81f4\u3002\u7d50\u679c\u8868\u660e\uff0c\u5728\u7dad\u6301\u6cbb\u7642\u671f\u9593\u76e3\u6e2c\u5faa\u74b0\u6fc3\u5ea6\u662f\u5176\u4ed6\u526f\u4f5c\u7528\u7684\u76f4\u63a5\u548c\/\u6216\u9593\u63a5\u56e0\u7d20\u3002<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Target<\/td>\nBevacizumab<\/td>\n<\/tr>\n
Reactivity<\/td>\nHuman<\/td>\n<\/tr>\n
Tested Applications<\/td>\nELISA<\/td>\n<\/tr>\n
Recommended dilutions<\/td>\nOptimal dilutions\/concentrations should be determined by the end user.<\/td>\n<\/tr>\n
Storage<\/td>\nShipped at 4 \u00b0C. Upon receipt, store the kit according to the storage instruction in the kit’s manual.<\/td>\n<\/tr>\n
Validity<\/td>\nThe validity for this kit is 6 months.<\/td>\n<\/tr>\n
Stability<\/td>\nThe stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.<\/td>\n<\/tr>\n
Test Range<\/td>\n0.31 \u03bcg\/ml – 5 \u03bcg\/ml<\/td>\n<\/tr>\n
Sensitivity<\/td>\n0.16 \u03bcg\/ml<\/td>\n<\/tr>\n
Detection Method<\/td>\nColorimetric<\/td>\n<\/tr>\n
Assay Data<\/td>\nQuantitative<\/td>\n<\/tr>\n
Sample Type<\/td>\nSerum and plasma.<\/td>\n<\/tr>\n
Availability<\/td>\nShipped within 5-12 working days.<\/td>\n<\/tr>\n
Note<\/td>\n\n

This product is for research use only.<\/p>\n

The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.<\/p>\n

Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Please see our extensive range of biosimilar ELISA kits available for research below:<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Biosimilar ELISA Kits<\/b><\/h4>\n<\/td>\n

\n

View All<\/a><\/h4>\n<\/td>\n<\/tr>\n<\/thead>\n

Adalimumab ELISA Kit<\/td>\nabx395016<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Afasevikumab ELISA Kit<\/td>\nabx395146<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Afutuzumab ELISA Kit<\/td>\nabx395063<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Alacizumab ELISA Kit<\/td>\nabx395113<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Amatuximab ELISA Kit<\/td>\nabx395135<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Andecaliximab ELISA Kit<\/td>\nabx395073<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Anetumab Ravtansine ELISA Kit<\/td>\nabx395136<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Anifrolumab ELISA Kit<\/td>\nabx395089<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Apamistamab ELISA Kit<\/td>\nabx395051<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ascrinvacumab ELISA Kit<\/td>\nabx395115<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Astegolimab ELISA Kit<\/td>\nabx395124<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Atezolizumab ELISA Kit<\/td>\nabx395168<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Avelumab ELISA Kit<\/td>\nabx395169<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Balstilimab ELISA Kit<\/td>\nabx395139<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Basiliximab ELISA Kit<\/td>\nabx395022<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Befovacimab ELISA Kit<\/td>\nabx395059<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Belantamab ELISA Kit<\/td>\nabx395125<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Benufutamab ELISA Kit<\/td>\nabx395000<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Bimagrumab ELISA Kit<\/td>\nabx395105<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Bimekizumab ELISA Kit<\/td>\nabx395147<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Blosozumab ELISA Kit<\/td>\nabx395163<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Brolucizumab ELISA Kit<\/td>\nabx395077<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cabiralizumab ELISA Kit<\/td>\nabx395044<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Camidanlumab ELISA Kit<\/td>\nabx395023<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Canakinumab ELISA Kit<\/td>\nabx395020<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Carlumab ELISA Kit<\/td>\nabx395069<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cergutuzumab ELISA Kit<\/td>\nabx395042<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Certolizumab ELISA Kit<\/td>\nabx395017<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cetrelimab ELISA Kit<\/td>\nabx395140<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cinpanemab ELISA Kit<\/td>\nabx395116<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cixutumumab ELISA Kit<\/td>\nabx395046<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Clazakizumab ELISA Kit<\/td>\nabx395038<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Codrituzumab ELISA Kit<\/td>\nabx395123<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Conatumumab ELISA Kit<\/td>\nabx395001<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Concizumab ELISA Kit<\/td>\nabx395060<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Crizanlizumab ELISA Kit<\/td>\nabx395080<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Cusatuzumab ELISA Kit<\/td>\nabx395110<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Daclizumab ELISA Kit<\/td>\nabx395024<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Dalotuzumab ELISA Kit<\/td>\nabx395047<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Daratumumab ELISA Kit<\/td>\nabx395106<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Depatuxizumab ELISA Kit<\/td>\nabx395009<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Dilpacimab ELISA Kit<\/td>\nabx395166<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Disitamab ELISA Kit<\/td>\nabx395033<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Drozitumab ELISA Kit<\/td>\nabx395002<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Dupilumab ELISA Kit<\/td>\nabx395100<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Durvalumab ELISA Kit<\/td>\nabx395170<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Edrecolomab ELISA Kit<\/td>\nabx395087<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Eldelumab ELISA Kit<\/td>\nabx395028<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Elezanumab ELISA Kit<\/td>\nabx395160<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Emactuzumab ELISA Kit<\/td>\nabx395045<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Emibetuzumab ELISA Kit<\/td>\nabx395052<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Enfortumab Vedotin ELISA Kit<\/td>\nabx395161<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Enoblituzumab ELISA Kit<\/td>\nabx395154<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Epcoritamab ELISA Kit<\/td>\nabx395064<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Faricimab ELISA Kit<\/td>\nabx395005<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Farletuzumab ELISA Kit<\/td>\nabx395074<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Favezelimab ELISA Kit<\/td>\nabx395093<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Figitumumab ELISA Kit<\/td>\nabx395048<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Foravirumab ELISA Kit<\/td>\nabx395176<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Frovocimab ELISA Kit<\/td>\nabx395157<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ganitumab ELISA Kit<\/td>\nabx395049<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Gevokizumab ELISA Kit<\/td>\nabx395021<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Glembatumumab ELISA Kit<\/td>\nabx395138<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Glofitamab ELISA Kit<\/td>\nabx395065<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Golimumab ELISA Kit<\/td>\nabx395018<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Gremubamab ELISA Kit<\/td>\nabx395180<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ianalumab ELISA Kit<\/td>\nabx395162<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ibalizumab ELISA Kit<\/td>\nabx395025<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ibritumomab ELISA Kit<\/td>\nabx395066<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Icrucumab ELISA Kit<\/td>\nabx395090<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ieramilimab ELISA Kit<\/td>\nabx395091<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ifabotuzumab ELISA Kit<\/td>\nabx395107<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Iladatuzumab ELISA Kit<\/td>\nabx395117<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Imalumab ELISA Kit<\/td>\nabx395072<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Inclacumab ELISA Kit<\/td>\nabx395081<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Indatuximab ELISA Kit<\/td>\nabx395094<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Infliximab ELISA Kit<\/td>\nabx395019<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ipilimumab ELISA Kit<\/td>\nabx395084<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Iscalimab ELISA Kit<\/td>\nabx395101<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Itolizumab ELISA Kit<\/td>\nabx395109<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ivuxolimab ELISA Kit<\/td>\nabx395119<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ixekizumab ELISA Kit<\/td>\nabx395148<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Labetuzumab ELISA Kit<\/td>\nabx395043<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lacnotuzumab ELISA Kit<\/td>\nabx395054<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lenzilumab ELISA Kit<\/td>\nabx395029<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Letolizumab ELISA Kit<\/td>\nabx395108<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lexatumumab ELISA Kit<\/td>\nabx395003<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lintuzumab ELISA Kit<\/td>\nabx395095<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lirilumab ELISA Kit<\/td>\nabx395122<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lodelcizumab ELISA Kit<\/td>\nabx395158<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lorvotuzumab ELISA Kit<\/td>\nabx395070<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Losatuxizumab ELISA Kit<\/td>\nabx395010<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Lupartumab ELISA Kit<\/td>\nabx395008<\/td>\nView Here<\/a><\/span><\/td>\n<\/tr>\n
Magrolimab ELISA Kit<\/td>\nabx395132<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Marstacimab ELISA Kit<\/td>\nabx395061<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Mavezelimab ELISA Kit<\/td>\nabx395092<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Meplazumab ELISA Kit<\/td>\nabx395112<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Milatuzumab ELISA Kit<\/td>\nabx395032<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Mirikizumab ELISA Kit<\/td>\nabx395165<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Mirvetuximab ELISA Kit<\/td>\nabx395075<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Mirzotamab ELISA Kit<\/td>\nabx395155<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Mosunetuzumab ELISA Kit<\/td>\nabx395067<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Namilumab ELISA Kit<\/td>\nabx395030<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Navicixizumab ELISA Kit<\/td>\nabx395167<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Necitumumab ELISA Kit<\/td>\nabx395011<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Nesvacumab ELISA Kit<\/td>\nabx395006<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Nirsevimab ELISA Kit<\/td>\nabx395172<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Nivolumab ELISA Kit<\/td>\nabx395141<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Obiltoxaximab ELISA Kit<\/td>\nabx395179<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Obinutuzumab ELISA Kit<\/td>\nabx395062<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ocaratuzumab ELISA Kit<\/td>\nabx395068<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Olaratumab ELISA Kit<\/td>\nabx395082<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Oleclumab ELISA Kit<\/td>\nabx395096<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Olokizumab ELISA Kit<\/td>\nabx395039<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Omburtamab ELISA Kit<\/td>\nabx395156<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ontamalimab ELISA Kit<\/td>\nabx395137<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Otilimab ELISA Kit<\/td>\nabx395031<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Oxelumab ELISA Kit<\/td>\nabx395099<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Pacmilimab ELISA Kit<\/td>\nabx395171<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Palivizumab ELISA Kit<\/td>\nabx395173<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Panitumumab ELISA Kit<\/td>\nabx395012<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Pasotuxizumab ELISA Kit<\/td>\nabx395127<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Pembrolizumab ELISA Kit<\/td>\nabx395142<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Pertuzumab ELISA Kit<\/td>\nabx395034<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Pogalizumab ELISA Kit<\/td>\nabx395120<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Polatuzumab ELISA Kit<\/td>\nabx395118<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Rafivirumab ELISA Kit<\/td>\nabx395177<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ramucirumab ELISA Kit<\/td>\nabx395114<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ranibizumab ELISA Kit<\/td>\nabx395078<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Remtolumab ELISA Kit<\/td>\nabx395149<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Rolinsatamab ELISA Kit<\/td>\nabx395088<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Romosozumab ELISA Kit<\/td>\nabx395164<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Rosopatamab ELISA Kit<\/td>\nabx395128<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Sacituzumab ELISA Kit<\/td>\nabx395055<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Secukinumab ELISA Kit<\/td>\nabx395150<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Semorinemab ELISA Kit<\/td>\nabx395056<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Serclutamab ELISA Kit<\/td>\nabx395013<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Sibrotuzumab ELISA Kit<\/td>\nabx395133<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Simlukafusp Alfa ELISA Kit<\/td>\nabx395134<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Sintilimab ELISA Kit<\/td>\nabx395143<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Sirukumab ELISA Kit<\/td>\nabx395040<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Suptavumab ELISA Kit<\/td>\nabx395174<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Suvizumab ELISA Kit<\/td>\nabx395175<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Talacotuzumab ELISA Kit<\/td>\nabx395103<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tanezumab ELISA Kit<\/td>\nabx395015<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tarextumab ELISA Kit<\/td>\nabx395129<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tavolimab ELISA Kit<\/td>\nabx395121<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Teclistamab ELISA Kit<\/td>\nabx395126<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Teprotumumab ELISA Kit<\/td>\nabx395050<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tesidolumab ELISA Kit<\/td>\nabx395014<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tezepelumab ELISA Kit<\/td>\nabx395159<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tibulizumab ELISA Kit<\/td>\nabx395151<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tigatuzumab ELISA Kit<\/td>\nabx395004<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tilavonemab ELISA Kit<\/td>\nabx395057<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tiragolumab ELISA Kit<\/td>\nabx395153<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tislelizumab ELISA Kit<\/td>\nabx395144<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tisotumab ELISA Kit<\/td>\nabx395071<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tocilizumab ELISA Kit<\/td>\nabx395053<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Toripalimab ELISA Kit<\/td>\nabx395145<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tosatoxumab ELISA Kit<\/td>\nabx395178<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tovetumab ELISA Kit<\/td>\nabx395083<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Trastuzumab ELISA Kit<\/td>\nabx395035<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tregalizumab ELISA Kit<\/td>\nabx395026<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Tremelimumab ELISA Kit<\/td>\nabx395085<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Urelumab ELISA Kit<\/td>\nabx395130<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Utomilumab ELISA Kit<\/td>\nabx395131<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Vanucizumab ELISA Kit<\/td>\nabx395007<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Varisacumab ELISA Kit<\/td>\nabx395079<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Varlilumab ELISA Kit<\/td>\nabx395102<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Vibecotamab ELISA Kit<\/td>\nabx395104<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Vofatamab ELISA Kit<\/td>\nabx395098<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Vorsetuzumab ELISA Kit<\/td>\nabx395111<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Vunakizumab ELISA Kit<\/td>\nabx395152<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zagotenemab ELISA Kit<\/td>\nabx395058<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zalifrelimab ELISA Kit<\/td>\nabx395086<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zampilimab ELISA Kit<\/td>\nabx395097<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zanidatamab ELISA Kit<\/td>\nabx395036<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zanolimumab ELISA Kit<\/td>\nabx395027<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Zenocutuzumab ELISA Kit<\/td>\nabx395037<\/td>\nView Here<\/a><\/td>\n<\/tr>\n
Ziltivekimab ELISA Kit<\/td>\nabx395041<\/td>\nView Here<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u751f\u7269\u4eff\u88fd\u85e5ELISA\u6aa2\u6e2c | Research into Biosimilar antibodies Bios […]<\/p>\n","protected":false},"author":3,"featured_media":33274,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5340],"tags":[5812],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/42921"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42921"}],"version-history":[{"count":1,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/42921\/revisions"}],"predecessor-version":[{"id":42922,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/42921\/revisions\/42922"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/33274"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42921"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}